Sign Up to like & get
recommendations!
1
Published in 2019 at "International Immunopharmacology"
DOI: 10.1016/j.intimp.2019.02.015
Abstract: &NA; The relationship between inflammation and formation of reactive oxygen species (ROS) is still not completely understood and excessive inflammatory reaction is attributed to increased yet also to reduced ROS formation. To compare ROS formation…
read more here.
Keywords:
rheumatic patients;
biological therapy;
inflammation;
ros ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Rheumatology"
DOI: 10.1093/rheumatology/kead236
Abstract: OBJECTIVES B cell depleting monoclonal antibodies are associated with increased COVID-19 severity and impaired immune response to vaccination. We aimed to assess the humoral and cell mediated (CMI) immune response after SARS-CoV-2 vaccination in rituximab…
read more here.
Keywords:
vaccination;
treated rheumatic;
rheumatic patients;
cell mediated ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2021-eular.3488
Abstract: The severe measures of lockdown imposed in Italy to limit the SARS coronavirus 2 disease (COVID-19) spread caused an increase of reported anxiety, depression and suicidal rate among general population. Patients affected by rheumatic disorders…
read more here.
Keywords:
covid lockdown;
zung;
rheumatic patients;
approach ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2021-eular.4057
Abstract: Pneumocystis jiroveci pneumonia (PJP) is an opportunistic infection affecting immunocompromised individuals. Due to its high mortality, PJP prophylaxis is commonly recommended for many immunocompromising conditions. However, evidence regarding the burden and role of prophylaxis in…
read more here.
Keywords:
among rheumatic;
pjp;
mortality;
prophylaxis ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Annals of Clinical Microbiology and Antimicrobials"
DOI: 10.1186/s12941-021-00483-2
Abstract: Background Pneumocystis jiroveci pneumonia (PJP) is an opportunistic infection affecting immunocompromised individuals. However, evidence regarding the burden and effectiveness of prophylaxis among rheumatic patients remains limited. Delineating the epidemiology and efficacy of prophylaxis among rheumatic…
read more here.
Keywords:
rheumatic patients;
pjp;
mortality;
prophylaxis ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Advances in Rheumatology"
DOI: 10.1186/s42358-018-0016-x
Abstract: IntroductionInfliximab infusion generally occurs in 2–4 h. Recent studies have suggested the possibility of accelerated infusion (1 h) of this drug.ObjectiveTo evaluate the safety of accelerated infliximab infusion in patients with rheumatic diseases. In addition, patient satisfaction…
read more here.
Keywords:
satisfaction;
rheumatic patients;
infusion;
safety ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Cellular and Infection Microbiology"
DOI: 10.3389/fcimb.2022.941930
Abstract: Background The effectiveness of metagenomic next-generation sequencing (mNGS) in respiratory pathogen detection and clinical decision-making in critically rheumatic patients remains largely unexplored. Methods A single-center retrospective study of 58 rheumatic patients who were admitted to…
read more here.
Keywords:
diagnosis;
suspected pneumonia;
rheumatic patients;
next generation ... See more keywords